BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background Fibroblast cells have the ability to improve skin conditions through regenerative
medicine and cell-based therapies. The purpose of this scoping review is to assess the …

Venous disease is prevalent, undertreated, and frequently unrecognized. During the past
two decades, new treatment modalities have changed how venous disease is approached …

Objective Superficial venous disease has a US prevalence of nearly 30%, with advanced
disease contributing to a significant healthcare burden. Although the risk factors for venous …

Objective: In previous studies, venous ulcers (VUs) have been found to occur more often in
patients with lower socioeconomic status. The aim of this study was to explore if …

Background Varicose veins, affecting 8-10% of the population, are categorized as primary or
secondary, depending on the etiology. The aim of the study is to assess the clinical profile of …

Background: Chronic venous leg ulcers (VLUs) are a common manifestation of chronic
venous insufficiency, accounting for up to 70% of all chronic leg ulcers. Patients sustained …

Varicose veins represent a pathology with a frequent number of cases that require surgical
treatment. High saphenous ligation and stripping is still a feasible surgical intervention in …

Chronic venous disease is an underrecognized disease process that contributes to a large
economic healthcare burden. Understanding its epidemiology, pathophysiology, and …